3-((1-Benzyl-1H-Indazol-3-Yl)Oxy)-N,N-Dimethylpropan-1-Amine Hydrochloride 3-((1-苄基-1H-吲唑-3-基)氧基)-N,N-二甲基丙烷-1-胺盐酸盐

CAS 132-69-4 MFCD00078957

化学结构图

132-69-4
SMILES: CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl

化学属性

Mol. FormulaC19H24ClN3O
Mol. Weight346
TSCANo
Melting Point157.0 to 162.0 deg-C
Appearance 盐酸苄达明(132-69-4)为白色结晶性粉末。熔点160℃，易溶于水、乙醇、氯仿，难溶于乙醚。无臭，味辛辣。
SolubilityDMSO 69 mg/mL Water 69 mg/mL Ethanol 69 mg/mL

别名和识别编码

Chemical Name3-((1-Benzyl-1H-Indazol-3-Yl)Oxy)-N,N-Dimethylpropan-1-Amine Hydrochloride
CAS Number132-69-4
Synonym ririlim BENZYDAMINE HCL Difflam Benzydamine hydrochloride indolin 1-苄基-3-(3-[二甲基氨基]丙氧基)-1H-吲唑盐酸盐 苄达明 盐酸盐 difflam 1-苄基-3-[3-(二甲基氨基)丙氧基]-1H-吲唑 消炎灵 Benzidamine hydrochloride Benalgin 1-Benzyl-3-(3-[dimethylamino]propoxy)-1H-indazole hydrochloride 1-Benzyl-3-gamma-dimethylaminopropoxy-1H-indazole hydrochloride Benzyrin imotryl benalgin LABOTEST-BB LT00771795 Enzamin benzidaminehydrochloride 1-苄基-3-[3-(二甲氨基)丙氧基]-1H-吲唑盐酸盐 n,n-dimethyl-3-((1-(phenylmethyl)-1h-indazol-3-yl)oxy)-1-propanaminhydro 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-, 1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole hydrochloride Dorinamin 盐酸炎痛静 苄达明 盐酸盐;1-苄基-3-[3-(二甲氨基)丙氧基]-1H-吲唑盐酸盐 BENZYDAMINE HYDROCHLORIDE 苄吲胺唑 ######## benzyrin enzamin epirotin dorinamin 1-benzyl-3-(3-(dimethylamino)propoxy)-1h-indazolmonohydrochloride AF 864 Imotryl Epirotin 1-BENZYL-3-[3-(DIMETHYLAMINO)-PROPOXY]-1H-INDAZOLE HYDROCHLORIDE benzindaminehydrochloride af864 盐酸苄达明 Benzindamine hydrochloride Indolin 1-benzyl-3-gamma-dimethylaminopropoxy-1h-indazolehydrochloride riripen
MDL NumberMFCD00078957
PubChem Substance ID65464
EC Number205-076-0
Merck Number1122
Reaxys-RN4282836
Chemical Name Translation3-((1-苄基-1H-吲唑-3-基)氧基)-N,N-二甲基丙烷-1-胺盐酸盐
Wiswesser Line NotationT56 BNNJ B1R& DO3N1&1 &GH
InChIInChI=1S/C19H23N3O.ClH/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16;/h3-7,9-12H,8,13-15H2,1-2H3;1H
LabNetwork Molecule IDLN00196697
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Heterocycles
  • {SNA} Alphabetical Index of Analytical Standards, Analytical Standards, B, BA - BH, Chromatography, Drugs & Metabolites, Forensic and Veterinary Standards, Neat Compounds, 分析/色谱
  • Pharmaceuticals
  • Amines
  • {SNA} Alphabetical Index of Analytical Standards, Analytical Standards, Analytical/Chromatography, B, BA - BH, Chromatography, Drugs & Metabolites, Forensic and Veterinary Standards, Neat Compounds
  • Intermediates & Fine Chemicals
  • {SNA} Alphabetic, Analytical Standards, Analytical/Chromatography, B, BA - BH, Chromatography, Drugs & Metabolites,

产品应用

  • A nonsteroidal anti-inflammatory drug with local anaesthetic, analgesic and antipyretic properties.

相关文献及参考

  • Passali, D., et al.: Clin. Ther., 23, 1508 (2001),

安全信息

WGK Germany3
GHS Symbol
Precautionary statements
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
  • P305+P351+P338
  • P305+P351+P338+P337+P313
  • P301+P312+P330
  • P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西，喝水或吸烟。
  • P337+P313
Hazard statements
  • H302 Harmful if swallowed 吞食有害
  • H319 Causes serious eye irritation 严重刺激眼睛
Signal word Warning
Hazard Codes Xn
Safety Statements
  • S36 Wear suitable protective clothing 穿戴适当的防护服；
  • S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后，立即用大量水冲洗并征求医生意见；
  • S9 Keep container in a well-ventilated place 保持容器在通风良好的场所；
  • S60 This material and its container must be disposed of as hazardous waste 该物质及其容器必须作为危险废物处置；
  • S36/37 Wear suitable protective clothing and gloves 穿戴适当的防护服和手套；
Risk Statements
  • R36 Irritating to eyes 刺激眼睛
  • R20/21/22 Harmful by inhalation, in contact with skin and if swallowed 吸入、皮肤接触和不慎吞咽有害
RTECSNK7875000
Storage condition 0-10 储存温度-20°C 0-10°C 2-8°C 
TYPE OF TEST            : TDLo - Low

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 110 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Behavioral - convulsions or effect on seizure threshold
   Behavioral - muscle weakness
REFERENCE :
   TXAPA9 Toxicology and Applied Pharmacology.  (Academic Press, Inc., 1 E.
   First St., Duluth, MN 55802) V.1-    1959-  Volume(issue)/page/year:
   10,148,1967

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 218 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Behavioral - convulsions or effect on seizure threshold
   Behavioral - muscle weakness
REFERENCE :
   TXAPA9 Toxicology and Applied Pharmacology

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 740 mg/kg
TOXIC EFFECTS :
   Behavioral - tremor
   Behavioral - convulsions or effect on seizure threshold
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   YKKZAJ Yakugaku Zasshi.  Journal of Pharmacy.  (Nippon Yakugakkai, 2-12-15
   Shibuya, Shibuya-ku, Tokyo 150, Japan)  No.1-    1881-
   Volume(issue)/page/year: 99,240,1979

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 720 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   OYYAA2 Oyo Yakuri.  Pharmacometrics.  (Oyo Yakuri Kenkyukai, CPO Box 180,
   Sendai 980-91, Japan) V.1-    1967-  Volume(issue)/page/year: 2,70,1968

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 240 mg/kg
SEX/DURATION            : female 7-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
   Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
   gain)
REFERENCE :
   SKNEA7

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 900 mg/kg
SEX/DURATION            : female 10-15 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 600 mg/kg
SEX/DURATION            : female 8-13 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
REFERENCE :
   OYYAA2 Oyo Yakuri.  Pharmacometrics.  (Oyo Yakuri Kenkyukai, CPO Box 180,
   Sendai 980-91, Japan) V.1-    1967-  Volume(issue)/page/year: 3,271,1969

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 180 mg/kg
SEX/DURATION            : female 10-15 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
REFERENCE :
   OYYAA2 Oyo Yakuri.  Pharmacometrics.  (Oyo Yakuri Kenkyukai, CPO Box 180,
   Sendai 980-91, Japan) V.1-    1967-  Volume(issue)/page/year: 3,271,1969

TYPE OF TEST            : TDL

TYPE OF TEST            : TDLo - Lowest published toxic dose

其他信息

  • 储运特性:通风低温干燥; 与库房食品原料分开存放
  • 可燃性危险特性:可燃; 燃烧产生有毒氮氧化物和氯化氢烟雾
  • 毒性分级:高毒
  • 苄达明 盐酸盐
  • 方法一:以邻氨基苯甲酸为原料，经重氮化、还原、环合、烃化、缩合、成盐等化学反应生成苄达明。具体操作如下：（1）重氮化 边搅拌边将邻氨基苯甲酸加入一定量水中，加浓盐酸，使反应物溶解，再加盐酸使结晶析出。冷至3℃以下，缓缓滴加亚硝酸钠水溶液，温度不超过3℃，继续搅拌，得透明茶色重氮盐溶液。（2）还原 在10℃以下，将重氮盐溶液滴入二氧化硫饱和溶液中，静置后加浓盐酸，搅拌下有结晶析出，冷至5℃以下，放置、过滤、抽干得邻肼基苯甲酸盐酸盐。（3）环合 将还原物以及水、盐回流30分钟、浓缩、趁热用碳酸钠中和至pH为7，放置，过滤、水洗、干燥，得3-羟基吲哒唑。（4）烃化 将环合物及无水乙醇、氢氧化钠加热回流，冷后过滤，滤液冷冻过夜析出结晶，过滤、干燥，即得1-苄基-3-羟基吲哒唑。（5）缩合 将烃化物、二甲苯及切碎的金属钠加热回流，边搅拌边升温至金属钠融化，有白色气体产生。停止加热，反应物变稠至糊状，滴加二甲氨基氯丙烷与甲苯的混合液，滴完后继续回流反应。放冷、过滤、用二甲苯洗。将滤液与洗液合并，用稀盐酸萃取，加液碱，析出油层，以无水硫酸钠干燥。此即为苄达明游离碱，精制后按常法制成盐酸盐。
  • Sigma Aldrich:132-69-4(sigmaaldrich)
  • MOL 文件:132-69-4.mol
  • 急性毒性:口服-大鼠 LD50: 740 毫克/公斤; 口服-小鼠 LD50: 440 毫克/公斤
  • 上游原料:Α-球蛋白 --> 二氧化硫 --> 邻氨基苯甲酸 --> 稀盐酸 --> 2-肼基苯甲酸盐酸盐 --> 6,7,8-三氟-1,4-二氢-4-氧代-喹啉-3-羧酸乙酯 --> 茶色 --> 苄达明
  • 用途一:本品为非特异性消炎药物，具有消炎，解热、镇痛作用。对因炎症引起的疼痛有效。抗炎作用与保泰松相似或稍强。本品尚有罂粟碱样解痉作用。常用于手术及外伤所致的各种炎症及关节炎、气管炎、咽炎等。可与抗菌素或磺胺类合用疗效更好。
  • 灭火剂:干粉,泡沫,沙土,二氧化碳, 雾状水
  • 类别:有毒物品

系列性分类

  1. Analytical & Chromatography 分析化学与色谱
  2. Analytical Standards
  3. Chromatography - Analytical Standards
  4. Forensic and Veterinary Standards - Chromatography
  5. Drugs & Metabolites - Forensic and Veterinary Standards
  6. Neat Compounds - Drugs & Metabolites
  1. Analytical & Chromatography 分析化学与色谱
  2. Analytical Standards
  3. Alphabetic - Analytical Standards
  4. B - Alphabetic
  5. BA - BH - B

相关产品推荐